Ischemic stroke subtypes and thrombophilia in young and elderly Brazilian stroke patients admitted to a rehabilitation hospital

Stroke. 2005 Sep;36(9):2012-4. doi: 10.1161/01.STR.0000177881.34840.cf. Epub 2005 Aug 18.

Abstract

Background and purpose: We sought to examine ischemic stroke subtypes and prevalence of thrombophilia in Brazilian stroke patients.

Method: A total of 130 consecutive young and 200 elderly stroke patients were studied.

Results: Prevalence of thrombophilia was, respectively: protein S deficiency (11.5% versus 5.5%), protein C deficiency (0.76% versus 1%), resistance to activated protein C (2.3% versus 3.5%), mutation in V Leiden factor (1.5% versus 2%), antithrombin III deficiency (0% versus 0%), lupus anticoagulant (0% versus 0.5%), anticardiolipin antibodies (3% versus 10%; P=0.01), hyperhomocysteinemia (31.5% versus 53.5%; P=0.0001), mutation of the MTHFR gene in homocigosis (10% versus 5%), and heterocigosis (27.6% versus 41.9%; P=0.01).

Conclusions: Prothrombotic conditions were more frequent in stroke of undetermined cause.

MeSH terms

  • Activated Protein C Resistance / blood
  • Adolescent
  • Adult
  • Age Factors
  • Aged
  • Antibodies, Anticardiolipin / chemistry
  • Brain Ischemia / pathology
  • Brain Ischemia / rehabilitation*
  • Brain Ischemia / therapy
  • Brazil
  • Cohort Studies
  • Factor V / genetics
  • Female
  • Hospitals
  • Humans
  • Hyperhomocysteinemia / pathology
  • Lupus Coagulation Inhibitor / chemistry
  • Lupus Coagulation Inhibitor / metabolism
  • Male
  • Middle Aged
  • Mutation
  • Prospective Studies
  • Protein C Deficiency / blood
  • Protein S Deficiency / blood
  • Rehabilitation / methods*
  • Risk Factors
  • Sex Factors
  • Stroke / complications
  • Stroke / epidemiology
  • Stroke / therapy
  • Stroke Rehabilitation*
  • Thrombophilia / complications*
  • Thrombosis

Substances

  • Antibodies, Anticardiolipin
  • Lupus Coagulation Inhibitor
  • factor V Leiden
  • Factor V